CTOs on the Move


 
SynGen advances regenerative medicine and other emerging applications for high-value cells by providing researchers, clinicians and manufacturers with innovative, robust systems that improve the recovery, purity and viability of stem and other clinically important cells from umbilical cord blood, peripheral blood, bone marrow, and cell culture.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.syngeninc.com
  • 2125 19th St Suite 120
    Sacramento, CA USA 95818
  • Phone: 916.706.0923

Executives

Name Title Contact Details

Similar Companies

Feelmore Labs

Innovative health and wellness technology company developing new consumer and medical devices, to help people live life better and more in tune with their bodies.

Ovid Therapeutics

Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.

Saint Margaret Mercy Healthcare Centers

Saint Margaret Mercy Healthcare Centers is a Hammond, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Electronic Child Health Network

Electronic Child Health Network is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Amrus Enterprises

Amrus Enterprises is a Fords, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.